ITM2B Gene Familial Danish Dementia (FDD) Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines

تحليل جين ITM2B للخرف العائلي الدنماركي (FDD) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Next-Generation Sequencing.
Premium Logistics: Paid Hospital-Grade Home Collection with ISO-Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM–11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed genetic counsellors.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

ملخص تنفيذي: يوفر اختبار التسلسل الجيني من الجيل التالي (NGS) لجين ITM2B دقة تشخيصية فائقة بنسبة 99.9% عبر مختبرات معتمدة آيزو وخدمة سحب منزلي متميزة مع دعم استشاري جيني بعد الفحص، مع إمكانية التحقق من التأمين عبر الواتساب.

Test Overview & Comparison

The ITM2B Gene Familial Danish Dementia (FDD) Genetic Test detects pathogenic variants in the ITM2B gene that cause autosomal dominant cerebral amyloid angiopathy with early-onset dementia. يفحص الاختبار الطفرات المسببة للخرف العائلي الدنماركي بدقة فائقة. Our UAE laboratory employs high-coverage NGS with clinical-grade bioinformatics, delivering a definitive diagnosis within 3–4 weeks.

Feature	Our Test (ITM2B NGS)	Closest Alternative
Precision & Sensitivity	99.9% sensitivity; full gene sequencing with copy number analysis	Targeted single-variant / Sanger sequencing; ~95% for known variants only
Methodology	Next-Generation Sequencing (NGS) on Illumina platform, ISO 15189 validated	Sanger sequencing; limited to one exon / known founder mutation
Turnaround Time	3–4 weeks (express options available)	4–6 weeks

Physician Insight & Safety Protocol

“As a DHA-licensed neurologist, I emphasize that a positive ITM2B result confirms a hereditary predisposition to familial Danish dementia, but clinical correlation with cognitive assessments and neuroimaging is essential. Genetic results must be integrated with your personal and family history to guide management. This test offers clarity, but it does not replace ongoing specialist care.”

— Dr. Prabhakar Reddy, DHA License: 61713011, Consultant Neurologist

⚠ Medication & Safety Advisory

Do not discontinue any prescribed medication or alter your treatment plan without consulting your doctor. Genetic testing is not a substitute for clinical management.

Exclusion Criteria & Urgent Red Flags

This genetic test is not indicated for minors under the age of consent, in strict compliance with UAE CDS Law 2026.
Individuals unable to provide informed consent or lacking a mandatory pre-test genetic counselling session (pedigree chart required) are ineligible.
Emergency Red Flags: If the patient experiences sudden, severe confusion, paralysis, or loss of consciousness, proceed directly to the nearest emergency department — DNA testing will not alter acute management.

Patient FAQ & Clinical Guidance

Q: ما هي دقة اختبار جين ITM2B للخرف العائلي الدنماركي؟

A: This NGS achieves 99.9% diagnostic sensitivity for known pathogenic ITM2B variants, ensuring near-definitive hereditary assessment. يحقق الاختبار حساسية تشخيصية بنسبة 99.9% للطفرات المسببة للخرف، مما يضمن تقييماً وراثياً شبه قاطع.

Q: كم يستغرق ظهور نتيجة فحص ITM2B NGS؟

A: Laboratory turnaround time is 3 to 4 weeks from sample receipt; express processing may reduce this by up to 5 business days. يستغرق تحليل العينة من 3 إلى 4 أسابيع، مع إمكانية تقليص المدة عبر الخدمة العاجلة.

Q: هل يغطي التأمين اختبار الخرف العائلي الدنماركي؟

A: Many UAE insurers partially cover medically necessary genetic tests when accompanied by a neurologist’s referral; direct billing verification is available via WhatsApp. تغطي العديد من شركات التأمين الإماراتية الفحص جينياً عند وجود تحويل طبيب أعصاب؛ ويتاح التحقق عبر الواتساب.

دعم ثنائي اللغة متاح